In response to EGFR, TRIM24 recruits STAT3 and stabilizes STAT3-chromatin interaction to promote cancer stem cell proliferation and maintenance.190 Given their role as transcriptional co-activators, the TRIMs have the potential to emerge as therapeutic targets in different pathological conditions. Here, STAT3 is linked to cancer.